Show simple item record

dc.contributor.authorYassour, Moran
dc.contributor.authorVatanen, Tommi
dc.contributor.authorSiljander, Heli
dc.contributor.authorHämäläinen, Anu-Maaria
dc.contributor.authorHärkönen, Taina
dc.contributor.authorRyhänen, Samppa J.
dc.contributor.authorFranzosa, Eric A.
dc.contributor.authorVlamakis, Hera
dc.contributor.authorHuttenhower, Curtis
dc.contributor.authorGevers, Dirk
dc.contributor.authorKnip, Mikael
dc.contributor.authorLander, Eric Steven
dc.contributor.authorXavier, Ramnik Joseph
dc.date.accessioned2018-06-29T18:33:37Z
dc.date.available2018-06-29T18:33:37Z
dc.date.issued2015-06
dc.identifier.issn1946-6234
dc.identifier.issn1946-6242
dc.identifier.urihttp://hdl.handle.net/1721.1/116700
dc.description.abstractThe gut microbial community is dynamic during the first 3 years of life, before stabilizing to an adult-like state. However, little is known about the impact of environmental factors on the developing human gut microbiome. We report a longitudinal study of the gut microbiome based on DNA sequence analysis of monthly stool samples and clinical information from 39 children, about half of whom received multiple courses of antibiotics during the first 3 years of life. Whereas the gut microbiome of most children born by vaginal delivery was dominated by Bacteroides species, the four children born by cesarean section and about 20% of vaginally born children lacked Bacteroides in the first 6 to 18 months of life. Longitudinal sampling, coupled with whole-genome shotgun sequencing, allowed detection of strain-level variation as well as the abundance of antibiotic resistance genes. The microbiota of antibiotic-treated children was less diverse in terms of both bacterial species and strains, with some species often dominated by single strains. In addition, we observed short-term composition changes between consecutive samples from children treated with antibiotics. Antibiotic resistance genes carried on microbial chromosomes showed a peak in abundance after antibiotic treatment followed by a sharp decline, whereas some genes carried on mobile elements persisted longer after antibiotic therapy ended. Our results highlight the value of high-density longitudinal sampling studies with high-resolution strain profiling for studying the establishment and response to perturbation of the infant gut microbiome.en_US
dc.description.sponsorshipNational Human Genome Research Institute (U.S.) (grant 2U54HG003067-10)en_US
dc.description.sponsorshipJuvenile Diabetes Research Foundation Internationalen_US
dc.description.sponsorshipNational Institutes of Health (U.S.) (grant U54 DK102557)en_US
dc.description.sponsorshipNational Institutes of Health (U.S.) (grant R01 DK092405)en_US
dc.description.sponsorshipNational Institutes of Health (U.S.) (grant P30 DK043351)en_US
dc.description.sponsorshipLeona M. and Harry B. Helmsley Charitable Trusten_US
dc.description.sponsorshipCrohn's and Colitis Foundation of Americaen_US
dc.publisherAmerican Association for the Advancement of Science (AAAS)en_US
dc.relation.isversionofhttp://dx.doi.org/10.1126/SCITRANSLMED.AAD0917en_US
dc.rightsCreative Commons Attribution-Noncommercial-Share Alikeen_US
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/en_US
dc.sourcePMCen_US
dc.titleNatural history of the infant gut microbiome and impact of antibiotic treatment on bacterial strain diversity and stabilityen_US
dc.typeArticleen_US
dc.identifier.citationYassour, Moran, Tommi Vatanen, Heli Siljander, Anu-Maaria Hämäläinen, Taina Härkönen, Samppa J. Ryhänen, Eric A. Franzosa, et al. “Natural History of the Infant Gut Microbiome and Impact of Antibiotic Treatment on Bacterial Strain Diversity and Stability.” Science Translational Medicine 8, no. 343 (June 15, 2016): 343ra81–343ra81.en_US
dc.contributor.departmentMassachusetts Institute of Technology. Center for Microbiome Informatics and Therapeuticsen_US
dc.contributor.departmentInstitute for Medical Engineering and Scienceen_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Biologyen_US
dc.contributor.mitauthorLander, Eric Steven
dc.contributor.mitauthorXavier, Ramnik Joseph
dc.relation.journalScience Translational Medicineen_US
dc.eprint.versionAuthor's final manuscripten_US
dc.type.urihttp://purl.org/eprint/type/JournalArticleen_US
eprint.statushttp://purl.org/eprint/status/PeerRevieweden_US
dc.date.updated2018-06-28T15:42:46Z
dspace.orderedauthorsYassour, Moran; Vatanen, Tommi; Siljander, Heli; Hämäläinen, Anu-Maaria; Härkönen, Taina; Ryhänen, Samppa J.; Franzosa, Eric A.; Vlamakis, Hera; Huttenhower, Curtis; Gevers, Dirk; Lander, Eric S.; Knip, Mikael; Xavier, Ramnik J.en_US
dspace.embargo.termsNen_US
mit.licenseOPEN_ACCESS_POLICYen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record